A detailed history of Berkshire Bank transactions in Novartis Ag stock. As of the latest transaction made, Berkshire Bank holds 4,885 shares of NVS stock, worth $528,215. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,885
Previous 4,483 8.97%
Holding current value
$528,215
Previous $452,000 4.42%
% of portfolio
0.12%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$95.27 - $108.47 $38,298 - $43,604
402 Added 8.97%
4,885 $472,000
Q4 2023

Jan 22, 2024

SELL
$92.27 - $101.54 $43,459 - $47,825
-471 Reduced 9.51%
4,483 $452,000
Q3 2023

Nov 01, 2023

SELL
$94.73 - $105.13 $11,367 - $12,615
-120 Reduced 2.36%
4,954 $504,000
Q2 2023

Jul 12, 2023

BUY
$92.52 - $104.91 $8,141 - $9,232
88 Added 1.76%
5,074 $512,000
Q1 2023

Apr 11, 2023

SELL
$80.03 - $92.81 $121,885 - $141,349
-1,523 Reduced 23.4%
4,986 $458,000
Q4 2022

Feb 02, 2023

SELL
$75.55 - $92.52 $357,804 - $438,174
-4,736 Reduced 42.12%
6,509 $590,000
Q3 2022

Nov 07, 2022

SELL
$74.61 - $87.26 $47,377 - $55,410
-635 Reduced 5.35%
11,245 $855,000
Q2 2022

Jul 15, 2022

SELL
$80.52 - $93.75 $12,722 - $14,812
-158 Reduced 1.31%
11,880 $1.01 Million
Q1 2022

Apr 21, 2022

SELL
$80.11 - $90.62 $99,416 - $112,459
-1,241 Reduced 9.35%
12,038 $1.06 Million
Q4 2021

Jan 28, 2022

SELL
$79.7 - $88.13 $307,084 - $339,564
-3,853 Reduced 22.49%
13,279 $1.16 Million
Q3 2021

Oct 14, 2021

SELL
$81.78 - $95.14 $102,961 - $119,781
-1,259 Reduced 6.85%
17,132 $1.4 Million
Q2 2021

Jul 26, 2021

SELL
$85.24 - $94.15 $747,043 - $825,130
-8,764 Reduced 32.27%
18,391 $1.68 Million
Q1 2021

Apr 19, 2021

SELL
$83.5 - $98.47 $68,303 - $80,548
-818 Reduced 2.92%
27,155 $2.32 Million
Q4 2020

Jan 27, 2021

BUY
$78.07 - $94.43 $20,844 - $25,212
267 Added 0.96%
27,973 $2.64 Million
Q3 2020

Nov 12, 2020

BUY
$82.14 - $91.0 $2.28 Million - $2.52 Million
27,706 New
27,706 $2.41 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Berkshire Bank Portfolio

Follow Berkshire Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Bank, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Bank with notifications on news.